Records containing: Lupus Erythematosus, Systemic

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

• CLINICAL_TRIALS study record update · 2013-08-15
  A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Test the Safety and Efficacy of Lipitor (Atorvastatin) in Reducing the Progression of Carotid IMT in Early Childhood SLE
• CLINICAL_TRIALS study record update · 2013-06-12
  Physical Therapy for Improvement of Quality of Life in Patients With Systemic Lupus Erythematosus (SLE)
• CLINICAL_TRIALS study record update · 2013-01-04
  A Randomized, Double-blind, Placebo-controlled, Single-dose, Dose-escalating Study to Evaluate Safety, Tolerability, Pharmacokinetics, Immunogenicity and to Explore the Pharmacodynamics of CDP7657 Administered in Healthy Subjects and in SLE Patients.
• CLINICAL_TRIALS study record update · 2012-10-08
  A Phase 1, Double-blind, Placebo-controlled, Multiple Intravenous, Ascending-Dose Study of CNTO 136 to Evaluate Safety and Pharmacokinetics in Subjects With Cutaneous Lupus Erythematosus and to Evaluate Safety and Pharmacokinetics in a Cohort of Subjects With Systemic Lupus Erythematosus
• CLINICAL_TRIALS study record update · 2012-10-08
  Rituximab in SLE: Understanding of Long-term Responses and the Impact of B Cell Depletion on T Cells
• Organize your saved records without ads with Plus.
• CLINICAL_TRIALS study record update · 2012-08-28
  A Phase 2, Multi-Center, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety, Tolerability, and Efficacy of LymphoStat-B™ Antibody (Monoclonal Anti-BLyS Antibody) in Subjects With Systemic Lupus Erythematosus (SLE)
• CLINICAL_TRIALS study record update · 2012-06-21
  A Single Center, Non-randomized, Placebo Controlled Study for the Evaluation of the Influence of Food Regimen on Oshadi D Absorption
• CLINICAL_TRIALS study record update · 2012-06-20
  Exploration of Genetic Polymorphisms Related to Individual Variations of Side Effects of Cyclophosphamide in Systemic Lupus Erythematosus Treatment
• CLINICAL_TRIALS study record update · 2012-04-03
  A Randomized Phase II Pharmacokinetics/Pharmacodynamics Study of Epratuzumab in Patients With Systemic Lupus Erythematosus
• CLINICAL_TRIALS study record update · 2011-11-15
  Ultrasound Evaluation of Hands in Patients With Systemic Lupus Erythematosus
• CLINICAL_TRIALS study record update · 2011-05-30
  ClinicalTrials.gov study NCT00025818
• CLINICAL_TRIALS study record update · 2010-12-10
  Randomized, Double-blind, Placebo-controlled, Multicenter, Phase II/III Study to Evaluate the Efficacy and Safety of Rituximab in Subjects With Moderate to Severe Systemic Lupus Erythematosus
• CLINICAL_TRIALS study record update · 2009-12-18
  An Open-label, Single-arm, Multicenter Phase II/III Extension Study to Evaluate the Safety of Rituximab Re-treatment in Subjects With Moderate to Severe Systemic Lupus Erythematosus Previously Enrolled in Protocol U2971g
• CLINICAL_TRIALS study record update · 2009-10-05
  A Double Blind, Randomized, Placebo Controlled, Multi-Center Trial of Anti-TNF-alpha Chimeric Monoclonal Antibody (Infliximab) and Azathioprine in Patients Suffering From Systemic Lupus Erythematosus (SLE) With WHO Class V Glomerulonephritis
• CLINICAL_TRIALS study record update · 2009-04-01
  A Randomized, Double-Blind, Placebo-Controlled, Three-Arm, Parallel-Group, Multicenter, Multinational Safety and Efficacy Trial of 300 mg and 900 mg of Abetimus Sodium in Systemic Lupus Erythematosus (SLE) Patients With a History of Renal Disease
• CLINICAL_TRIALS study record update · 2008-11-06
  Randomized Trial of High-Dose IV Cyclophosphamide Versus Monthly IV Cyclophosphamide
• CLINICAL_TRIALS study record update · 2006-10-25
  Fatigue and General Well-Being in Patients With Systemic Lupus Erythematosus or Primary Sjögren's Syndrome: Effects of Dehydroepiandrosterone Administration